We are looking at a small pilot project, 50-100 exomes (we prefer Illumina based core). Already have some exp with OtoGenetics but their SureSelect capture based option seems pricey. Anyone ? Thanks (not sure if that is the right category to ask for it but....)
Unconfigured Ad
Collapse
X
-
Originally posted by memento View PostWe are looking at a small pilot project, 50-100 exomes (we prefer Illumina based core). Already have some exp with OtoGenetics but their SureSelect capture based option seems pricey. Anyone ? Thanks (not sure if that is the right category to ask for it but....)Interrogate key biomarkers with our hybridisation-based FISH, NGS and array products for haematology, solid tumour, cytogenetics and rare disease. Learn more
Obvious disclaimer applies!
-
We've tested a number of exome service providers and are now going to regularly use Axeq.
We were quoted <£700 per exome using Nimblegen's latest capture.
We had a number of communication problems and delays with BGI.
Comment
-
$999 exome
We do $999 at the Columbia Genome Center. That includes all reagents, Agilent SureSelect XT Human All Exon v.2 44Mb, Library preparation, 60X depth mapped coverage, 100bp Paired End reads, sequenced on Illumina HiSeq2000 instruments, 2 months data storage, QC, reads mapped to the human reference genome, single nucleotide variants and short insertions/deletions, basic functional annotation of the variants, and summary statistics. Our average turnaround was 55 days last quarter.
I can send you recommendations from PIs who use our service. We take orders from all over the world.
We will be happy to answer any questions at [email protected]
Our FAQ is here:
Last edited by ocouronne; 02-21-2012, 10:58 AM.
Comment
-
so can you detail the problems?maybe we can give you feedback.Originally posted by TonyBrooks View PostWe've tested a number of exome service providers and are now going to regularly use Axeq.
We were quoted <£700 per exome using Nimblegen's latest capture.
We had a number of communication problems and delays with BGI.
Comment
-
Yeah,U're right!BGI-Europe will handle all issues in local region.Originally posted by Geneus View PostIf he is in the UK, shouldn't your European subsidiary be addressing these issues? Or do they lack the competence to do so?
Anyway,we'll try our best to do any kinds of problems.
you know customer forever is God!
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
17 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
27 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
Comment